Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZBTB8OSP1 (zinc finger and BTB domain containing 8 opposite strand pseudogene 1) is formally classified as a pseudogene in the human genome[1][3]. It is annotated as non-protein-coding and does not encode a functional protein product. The gene is related by sequence to the ZBTB8 gene family, which contains zinc finger and BTB (Broad-Complex, Tramtrack, and Bric à brac) domains often found in DNA-binding transcription factors. However, as a pseudogene, ZBTB8OSP1 lacks independent biological function as a receptor, enzyme, transporter, or signaling molecule. The broader scientific literature on pseudogenes suggests that some can influence the expression of their cognate genes by acting as competitive endogenous RNAs or microRNA decoys, but such a function has not been reported or experimentally established for ZBTB8OSP1 specifically[5]. No links to human disease, therapeutic targeting, or small molecule drug interactions are described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and BTB domain containing 8 opposite strand pseudogene 1 (ZBTB8OSP1).